News
COR
330.45
+1.68%
5.45
J.P. Morgan Sticks to Their Buy Rating for Cencora (COR)
TipRanks · 2h ago
Wells Fargo Gives a Buy Rating to Cencora (COR)
TipRanks · 3h ago
Weekly Report: what happened at COR last week (0803-0807)?
Weekly Report · 1d ago
Cencora: Strong U.S. Health Care Momentum and Solid Long‑Term EPS Outlook Underpin Buy Rating
TipRanks · 1d ago
Cencora price target raised to $346 from $342 at Morgan Stanley
TipRanks · 4d ago
Cencora (COR) Gets a Buy from Morgan Stanley
TipRanks · 4d ago
Analysts Conflicted on These Healthcare Names: Cencora (COR), Takeda Pharmaceutical Company (TAK) and Schrodinger (SDGR)
TipRanks · 4d ago
Cencora price target raised to $370 from $340 at Baird
TipRanks · 5d ago
Cencora price target raised to $430 from $412 at UBS
TipRanks · 5d ago
Allspring Growth Fund Q2 2026 Performance Update
Seeking Alpha · 5d ago
Cencora price target raised to $350 from $330 at Evercore ISI
TipRanks · 5d ago
Cencora price target raised to $370 from $355 at Citi
TipRanks · 5d ago
Barclays Sticks to Their Buy Rating for Cencora (COR)
TipRanks · 5d ago
Cencora Earnings Call Highlights Specialty-Driven Profit Surge
TipRanks · 5d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), American Well (AMWL) and BeOne Medicines (ONC)
TipRanks · 6d ago
Cencora declares $0.60 dividend
Seeking Alpha · 6d ago
Cencora Expands Credit Facilities to Bolster Liquidity
TipRanks · 6d ago
Cencora Raises 2026 EPS Outlook After Strong Quarter
TipRanks · 6d ago
Cencora: Fiscal Q3 Earnings Snapshot
Barchart · 6d ago
FTC probing Covetrus, MWI Animal Health deal - Bloomberg
Seeking Alpha · 6d ago
More
Webull provides a variety of real-time COR stock news. You can receive the latest news about Cencora Inc. through multiple platforms. This information may help you make smarter investment decisions.
About COR
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.